Literature DB >> 20653715

Diuretic management in heart failure.

G Michael Felker1.   

Abstract

Many of the primary clinical manifestations of heart failure are due to fluid retention and congestion, and therefore treatments targeting congestion play a central role in heart failure management. Diuretic therapy remains the cornerstone of congestion treatment, and diuretics are prescribed to the majority of heart failure patients. Despite this ubiquitous use, there is limited evidence from prospective randomized studies to guide the use of diuretics. Some observational data have suggested that diuretics may actually be harmful in heart failure, potentially contributing to worsening renal function, neurohormonal activation, and even heart failure progression. Recent clinical trial data have provided new insights into the balance of risks and benefits from diuretics. This review describes the mechanism of action of available diuretic classes, reviews their clinical use based on current guidelines, and briefly discusses evolving alternatives to diuretic therapy in the management of congestion in heart failure patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653715     DOI: 10.1111/j.1751-7133.2010.00172.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  12 in total

Review 1.  Diuretic Strategies in Acute Decompensated Heart Failure.

Authors:  E Ashley Hardin; Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2017-04

Review 2.  Diuretic Therapy in Heart Failure - Current Approaches.

Authors:  Gavino Casu; Pierluigi Merella
Journal:  Eur Cardiol       Date:  2015-07

3.  Sodium-glucose cotransporter 2 inhibitors and death and heart failure in type 2 diabetes.

Authors:  Hidekatsu Yanai
Journal:  Ann Transl Med       Date:  2017-12

Review 4.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

5.  Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure.

Authors:  David Pham; Justin L Grodin
Journal:  Card Fail Rev       Date:  2017-11

6.  A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics.

Authors:  Ertan Yetkin; Bilal Cuglan; Hasan Turhan; Selcuk Ozturk
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15

Review 7.  Ultrafiltration for acute heart failure.

Authors:  Mehul Srivastava; Nicholas Harrison; Ana Francisca Sma Caetano; Audrey R Tan; Mandy Law
Journal:  Cochrane Database Syst Rev       Date:  2022-01-21

8.  Beta-Blocker Dose Stratifies Mortality Risk in a Racially Diverse Heart Failure Population.

Authors:  Christelle Lteif; Meghan J Arwood; Mayank Kansal; Larisa H Cavallari; Ankit A Desai; Julio D Duarte
Journal:  J Cardiovasc Pharmacol       Date:  2020-03       Impact factor: 3.271

Review 9.  Heart failure: novel therapeutic approaches.

Authors:  C Patel; S Deoghare
Journal:  J Postgrad Med       Date:  2015 Apr-Jun       Impact factor: 1.476

Review 10.  Focus on renal congestion in heart failure.

Authors:  Baris Afsar; Alberto Ortiz; Adrian Covic; Yalcin Solak; David Goldsmith; Mehmet Kanbay
Journal:  Clin Kidney J       Date:  2015-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.